Reversible altered consciousness with brain atrophy caused by valproic acid

Pediatric Neurology

Volumn 28, Issue 5, 2003, Pages 382-384

  Yamanouchi, Hideo ^a   Ota, Takako ^b   Imataka, George ^b   Nakagawa, Eiji ^a   Eguchi, Mitsuoki ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b Shimotsuga General Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; PHENOBARBITAL; VALPROIC ACID;

ANAMNESIS; ARTICLE; BRAIN ATROPHY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONSCIOUSNESS DISORDER; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; HUMAN; LONG TERM CARE; PRESCHOOL CHILD; PRIORITY JOURNAL; TREATMENT WITHDRAWAL;

EID: 0038375855     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(03)00005-5     Document Type: Article

References (10)

1. Oechsner M., Steen C., Sturenburg H.J., Kohlschutter A. Hyperamonaemic encephalopathy after initiation of valproate therapy in unrecognised ornithine transcarbamylase. J Neurol Neurosurg Psychiatry. 64:1998;680-682.
2. Kifune A., Kubota F., Shibata N., Akata T., Kikuchi S. Valproic acid-induced hyperammonemic encephalopathy with triphasic waves. Epilepsia. 41:2000;909-912.
3. McLachlan R.S. Pseudoatrophy of the brain with valproic acid monotherapy. Can J Neurol Sci. 14:1987;294-296.
4. Papazian O., Canizales E., Alfonso I., Archila R., Duchowny M., Aicardi J. Reversible dementia and apparent brain atrophy during valproate therapy. Ann Neurol. 38:1995;687-691.
5. Guerrini R., Belmonte A., Canapicchi R., Casalini C., Perucca E. Reversible pseudoatrophy of the brain and mental deterioration associated with valproate treatment. Epilepsia. 39:1998;27-32.
6. Lam C.W., Lau C.H., Williams J.C., Chan Y., Wong L.J. Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) triggered by valproate therapy. Eur J Pediatr. 156:1997;562-564.
7. Chabrol B., Mancini J., Chretien D., Rstin P., Munnich A., Pinsard N. Valproate-induced hepatic failure in a case of cytochrome c oxidase deficiency. Eur J Paediatr. 153:1994;133-135.
8. Triggs W.J., Gilmore R.L., Millington D.S., Cibula J., Bunch T.S., Harman E. Valproate-associated carnitine deficiency and malignant cerebral edema in the absence of hepatic failure. Int J Clin Pharmacol Ther. 35:1997;353-356.
9. Marescaux C., Warter J.M., Micheletti G., Rumbach L., Coquillat G., Kurtz D. Stuporous episodes during treatment with sodium valproate Report of seven cases . Epilepsia. 23:1982;297-305.
10. Armon C., Shin C., Miller P., et al. Reversible parkinsonism and cognitive impairment with chronic valproate use. Neurology. 47:1996;626-635.